BAILLIE GIFFORD & CO 13D and 13G filings for NovoCure Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-09 06:15 am Sale |
2023-10-31 | 13G | NovoCure Limited NVCR |
BAILLIE GIFFORD & CO | 5,095,777 4.770% |
-3,768,065 (-42.51%) |
Filing |
| 2023-01-23 10:49 am Sale |
2022-12-30 | 13G | NovoCure Limited NVCR |
BAILLIE GIFFORD & CO | 8,863,842 8.450% |
-751,326 (-7.81%) |
Filing |
| 2022-01-26 09:17 am Purchase |
2021-12-31 | 13G | NovoCure Limited NVCR |
BAILLIE GIFFORD & CO | 9,615,168 9.260% |
1,354,093 (+16.39%) |
Filing |
| 2021-01-14 12:14 pm Purchase |
2020-12-31 | 13G | NovoCure Limited NVCR |
BAILLIE GIFFORD & CO | 8,261,075 8.120% |
252,093 (+3.15%) |
Filing |